Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 70

Results For "UK"

1036 News Found

Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar
News | November 21, 2022

Sonowal inaugurates Regional Research Institute of Unani Medicine in Silchar

The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine


IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
News | November 15, 2022

IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr

The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA


Orchid Pharma reports positive EBIDTA in Q2
News | November 15, 2022

Orchid Pharma reports positive EBIDTA in Q2

The company is focussed on increasing the capacity utilizations while controlling costs


Aurobindo Pharma Q2 FY23 revenue down 3.4%
News | November 14, 2022

Aurobindo Pharma Q2 FY23 revenue down 3.4%

Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore


IMPCL registers impressive threefold increase in profit for FY21-22
News | November 11, 2022

IMPCL registers impressive threefold increase in profit for FY21-22

The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal


Dr. Lucica Ditiu appreciates India's TB elimination response
Policy | November 11, 2022

Dr. Lucica Ditiu appreciates India's TB elimination response

Dr. Mandaviya agreed to host the Stop TB Partnership’s 36th Board meeting on March 25-26, 2023 in Varanasi


21.4 lakh TB cases notified in India in 2021
Policy | October 30, 2022

21.4 lakh TB cases notified in India in 2021

Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today


Mandaviya addresses Second G20 Health Ministers Meet
News | October 28, 2022

Mandaviya addresses Second G20 Health Ministers Meet

He also encouraged all G20 members to contribute their public keys to the proposed Global Federated Public Trust Directory for ensuring seamless worldwide mobility of people and goods


Quizartinib granted priority review in the U.S.
Drug Approval | October 26, 2022

Quizartinib granted priority review in the U.S.

Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone


Merck’s PREVYMIS effective for prevention of cytomegalovirus disease in adults post kidney transplantation
Clinical Trials | October 23, 2022

Merck’s PREVYMIS effective for prevention of cytomegalovirus disease in adults post kidney transplantation

Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint